Researchers at the University of Washington in Seattle reviewed findings on key pain management therapies and found that:
- Opioids were the most commonly prescribed drugs for pain, with sales increasing more than 175 percent from 1997-2006, yet they provide only small improvements in pain and function and have significant harmful side-effects.
- Epidural steroid injections in patients with radiculopathy have shown some efficacy with prolapsed lumbar discs.
- Lumbar fusion for back pain has shown some benefit, but are tied to high complication rates and repeat procedures.
- Nonsteroidal anti-inflammatory drugs can help in osteoarthritis and rheumatoid arthritis, but less is known about potential benefits for fibromyalgia or neuropathic pain.
- Gabapentin and pregabalin (Lyrica) are beneficial for neuropathic pain and fibromyalgia, but side effects include fatigue and weight gain.
Read the Lancet report on pain management.
Related Articles on Pain Management:
6 Ways Comprehensive Pain Management Clinics Differ from Pill Mills
Impact on Pain Management of the New Outcomes Research Institute: Q&A With Dr. Laxmaiah Manchikanti
Washington State Program to Continue Payment for Some Spinal Injections
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
